We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VITL icon
3826
Vital Farms
VITL
$468M
$15K ﹤0.01%
1,007
-1,213
-55% -$19.2K
VTYX
3827
DELISTED
Ventyx Biosciences
VTYX
$15K ﹤0.01%
444
-62
-12% -$2.41K
WOW
3828
DELISTED
WideOpenWest
WOW
$15K ﹤0.01%
1,460
+406
+39% +$4.39K
XLO icon
3829
Xilio Therapeutics
XLO
$60.3M
$15K ﹤0.01%
328
+24
+8% +$1.05K
XPER icon
3830
Xperi
XPER
$329M
$15K ﹤0.01%
1,373
-987
-42% -$10.3K
YI
3831
111 Inc
YI
$32.3M
$15K ﹤0.01%
555
+178
+47% +$5.22K
YORW icon
3832
York Water
YORW
$541M
$15K ﹤0.01%
346
+220
+175% +$9.84K
PDYN icon
3833
Palladyne AI
PDYN
$326M
$15K ﹤0.01%
5,392
+1,429
+36% +$4.99K
OKUR
3834
OnKure Therapeutics
OKUR
$162M
$15K ﹤0.01%
248
-344
-58% -$12.5K
HTB
3835
HomeTrust Bancshares
HTB
$834M
$15K ﹤0.01%
604
-24
-4% -$633
AMPS
3836
DELISTED
Altus Power
AMPS
$15K ﹤0.01%
2,702
-9,570
-78% -$67.2K
CUTR
3837
DELISTED
Cutera, Inc.
CUTR
$15K ﹤0.01%
643
-17,957
-97% -$574K
TCS
3838
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$15K ﹤0.01%
304
+70
+30% +$4.66K
ORGS
3839
DELISTED
Orgenesis Inc. Common Stock
ORGS
$15K ﹤0.01%
1,275
+96
+8% +$1.8K
ZLS
3840
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
$15K ﹤0.01%
1,428
-16
-1% -$162
SLCA
3841
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$15K ﹤0.01%
1,225
-3,070
-71% -$36.5K
CATC
3842
DELISTED
CAMBRIDGE BANCORP
CATC
$15K ﹤0.01%
234
+158
+208% +$12.2K
VERY
3843
DELISTED
Vericity, Inc. Common Stock
VERY
$15K ﹤0.01%
+1,975
New +$15.1K
EIGR
3844
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$15K ﹤0.01%
550
+291
+112% +$13.5K
APACU
3845
DELISTED
StoneBridge Acquisition Corporation Unit
APACU
$15K ﹤0.01%
1,469
DBTX
3846
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$15K ﹤0.01%
5,093
-4,885
-49% -$16.9K
PTRA
3847
DELISTED
Proterra Inc. Common Stock
PTRA
$15K ﹤0.01%
9,646
-13,482
-58% -$50.7K
TCFC
3848
DELISTED
The Community Financial Corporation Common Stock
TCFC
$15K ﹤0.01%
453
+363
+403% +$14K
SGHLU
3849
DELISTED
Signal Hill Acquisition Corp. Unit
SGHLU
$15K ﹤0.01%
1,424
MACK
3850
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$15K ﹤0.01%
1,235
-2,007
-62% -$23.6K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.